◄ back to all posts

CBM: Cambrex Corp. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 2,434.79
Book Value ($M) 675.89
Book Value / Share 20.04
Price / Book 2.99
NCAV ($M) -424.72
NCAV / Share -12.59
Price / NCAV -4.76

Profitability (mra)
Return on Invested Capital (ROIC) 0.10
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.17

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 2.37

Balance Sheet (mrq) ($M)
Current Assets 405.95
Assets 1,506.56
Liabilities 830.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 532.09
Operating Income 101.50
Net Income 92.42
Earnings Per Share Diluted 2.75
Earnings Per Share Basic 2.78

Cash Flow Statement (mra) ($M)
Cash From Operations 86.98
Cash from Investing -486.84
Cash from Financing -486.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-10 13G/A William Blair Investment Management, Llc 0.00 -100.00
2019-01-24 13G/A BlackRock Inc. 14.60 17.36
2019-01-10 13G/A Vanguard Group Inc 10.13 10.79
2018-02-05 13G/A Dimensional Fund Advisors Lp 4.22 -14.68
2015-02-02 13G/A Royce & Associates Lp 3.08
2014-01-07 13G/A Heartland Advisors Inc 4.90
2013-02-14 13G/A Neuberger Berman Group LLC 2.66
2012-02-14 13G/A WHV Investments, Inc. 4.23
2012-02-14 13G/A Ameriprise Financial Inc 0.60
2012-02-09 13G/A Snyder Capital Management L P 0.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-10-31 10-Q Quarterly Report – 10-Q

(click for more detail)

Similar Companies
BHVN – Biohaven Pharmaceutical Holding BMY – Bristol-Myers Squibb Co.
BXLT – Baxalta Incorporated CGC – Canopy Growth Corporation
CTLT – Catalent Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

401 K